Pay in 4 interest-free payments of $26.77 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
including DOT1
thereby resulting in the increasing Bax/Bcl-2 ratios
a novel histamine H2-receptor antagonist
121345-64-0
MEK162 was orally dosed to mice at 3-30 mg/kg once per day
PI-3065 Catalog No.:M8668-10 including DOT1PI3065 is a p110 isoform of phosphoinositide 3 OH kinase (PI(3)K) inhibitor. Inhibitors against the p110 isoform of phosphoinositide 3 OH kinase (PI(3)K) have shown remarkable therapeutic efficacy in some human leukaemias. As p110 is primarily expressed in leukocytes, drugs against p110 have not been considered for the treatment of solid tumours. p110 inactivation in regulatory T cells unleashes CD8(+) cytotoxic T cells and induces tumour regression.